Supplementary Figure 2 from Erlotinib Prolongs Survival in Pancreatic Cancer by Blocking Gemcitabine-Induced MAPK Signals
crossref（2023）
摘要
Supplementary Figure 2 PDF file - 97K, MEK inhibition reduced the gemcitabine-induced activation of EGFR and ErbB2 in the PDAC cells
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要